Crohn's & Colitis Foundation

Happy Diwali to all those who celebrate! 🪔✨
Celebrating festivals and cultural traditions while living with IBD can come with real questions, from navigating festive foods to managing energy and symptoms. Watch our conversation with SAIA, where a panel of experts and patient advocates share their perspectives: bit.ly/4sUOqZ5

Congratulations to our Team Challenge participants who took on the TCS New York City Marathon last weekend! Every mile and every dollar raised helps fuel progress for the 10 million people worldwide living with Crohn’s disease and ulcerative colitis.
Whether you were running for yourself or a loved one, you showed incredible strength and heart. Thank you for running with purpose. We’re cheering you on today and always!

More options for patients: The FDA has approved a subcutaneous treatment option for SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely active Crohn’s disease, giving patients more choice in how their drug is delivered. Contact our IBD Help Center with any questions: info@crohnscolitisfoundation.org.

For comprehensive information on IBD medications, including this new option, check out our IBD Medication Guide, designed to help you make informed decisions about your treatment in partnership with your healthcare team: bit.ly/4khMzbV

Crohn’s disease and ulcerative colitis can affect more than physical health. Cultural beliefs, access to care, and other barriers can make it difficult to talk about emotional well-being or seek support.

We asked people living with IBD and healthcare professionals to share their real experiences with the stigma surrounding mental health, the challenges of asking for help, the importance of culturally responsive care, and how breaking down barriers can help everyone find the support they need.

Watch the full series now. 🔗: bit.ly/4imFcRQ

This initiative is generously supported, in part, by Genentech and Eli Lilly. #Sponsored

🌟Keynote Spotlight🌟Drs. David Rubin & D. Brent Polk will present "The Evolution of IBD Care: Where Are We, and How We Got Here” at #CCCongress27. Registration & hotel discounts are still available—book today & we’ll see you in NOLA Jan. 21-23!
🔗 bit.ly/44q0t5k